Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 17,996 | N/A | N/A |
| TOTAL | $19,131 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 259 | N/A | N/A |
| TOTAL | $259 | $N/A | $N/A |
| Total Assets | $19,390 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,728 | 0 | 0 |
| Accrued Expenses | 509 | N/A | N/A |
| TOTAL | $2,237 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 872 | 0 | 0 |
| TOTAL | $872 | $N/A | $N/A |
| Total Liabilities | $3,109 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 2 | N/A | N/A |
| Retained earnings | -25,273 | N/A | N/A |
| TOTAL | $16,281 | $N/A | $N/A |
| Total Liabilities And Equity | $19,390 | $0 | $0 |